Immucor Schedules First Quarter Earnings Release And Conference Call
NORCROSS, Ga., Nov. 8 /PRNewswire-FirstCall/ -- Immucor, Inc. , the global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its first quarter earnings on Thursday, November 10, 2005, after the close of regular trading hours, and then host a conference call on Friday, November 11, 2005 at 8:30 a.m. (EST) to review the results. Investors are invited to participate in this conference call, with Edward L. Gallup, Chairman and Chief Executive Officer, Dr. Gioacchino De Chirico, President, and Patrick D. Waddy, Interim CFO. The call will focus on the results for the first quarter and general business trends. The earnings release will be posted on Immucor's website, as well as any financial information that may be discussed by Mr. Gallup, Dr. De Chirico or Mr. Waddy during this call not contained in the earnings release. Both the earnings release and the additional financial information, if any, will be posted as soon as practicable after the call on the investor news section of Immucor's website. To access this information once posted, go to Immucor's website at www.immucor.com and click on "Investor News."
To participate in the telephone conference call, dial 1-888-889-2036 and passcode Blud. Replays of the conference call will be available for one week beginning at 12:00 PM on November 11th by calling 1-866-448-7644. Beginning November 18, 2005, audio of the conference call or a transcript of the audio will be available on the "Investor News" page of the Immucor website.
For more information on Immucor, please visit our website at www.immucor.com.
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.Immucor, Inc.
CONTACT: Edward Gallup of Immucor, Inc., +1-770-441-2051
Web site: http://www.immucor.com/